Steven G. Felsher - 30 Sep 2026 Form 4 Insider Report for Modular Medical, Inc. (MODD)

SEC form
4
Accepted by SEC
01 Oct 2026, 18:42:07 UTC
Prior SEC filing
02 Jul 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Steven G. Felsher filed Form 4 for Modular Medical, Inc. (MODD) on 01 Oct 2026.

Key facts

  • This page summarizes Steven G. Felsher's Form 4 filing for Modular Medical, Inc. (MODD).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 01 Oct 2026, 18:42.

Change

  • Previous filing in this sequence was filed on 02 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001231460 Primary reporting owner

FELSHER STEVEN G

Relationship
Director

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MODD transaction

Common Stock

Award

Transaction value
Shares
+25
Change %
+0.29%
Price
Shares after
8,538
Date
30 Sep 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MODD transaction Derivative

Option to purchase common stock

Award

Transaction value
Shares
+250
Change %
Price
Shares after
250
Date
30 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
250
Exercise price
$1.95
Footnotes
F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

These shares were issued to the Reporting Person pursuant to the Issuer's Outside Director Compensation Plan.

Footnote F2

Share amount reflects the impact of a 1-for-30 reverse stock split of the Issuer's common stock effected on March 31, 2026.

Footnote F3

The option was granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the option was fully vested and exercisable on the grant date.

Footnote F4

In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .